Uploaded July 2026 | Updated September 2026, 2 weeks ago
A lot of people are involved in the development of new pharmaceutical products, from engineers to operators, c-level leadership and more. As a result, digital transformations can seem daunting, as everyone must buy into the process for it to be successful.
But how do you convince them all? Especially when considering the complexity and time involved getting new treatments to market. Well, what if they could cut that timeline in half? What if treatments could get in the hands of patients faster, safer and reliably?
In this podcast you will learn:
(00:36) Where pharmaceutical companies get stuck during digital transformations
(10:55) What the scalable success of digital transformations looks like
(15:45) Firsthand expert best practices for digital transformations
About the voices:
Jan Wokittel, Director of Smart Manufacturing at Roche (linkedin.com/in/janwokittel/)
Jan is responsible for the digitization technologies used in greenfield pharmaceutical and medical device production facilities. For over seven years, he has helped Roche plan and implement large scale capital expenditure projects.
Andy Whytock, Head of Market Strategy and Thought Leadership of Life Sciences at Siemens (linkedin.com/in/andywhytock/)
Andy is responsible for driving digital transformation initiatives and thought leadership activities in the pharmaceutical and life sciences sector and specializes in helping life sciences manufacturers embrace digital transformation, adopt cutting-edge technologies and evolve into fully connected, data-driven and sustainable enterprises.
Conor Peick, Marketing Professional for the Thought Leadership team at Siemens Digital Industries Software (linkedin.com/in/conor-peick-119ab2143/)
Conor is responsible for creating forward-looking content for Siemens Digital Industries Software. He collaborates with industry experts and executives to produce impactful content exploring the challenges companies face and the technologies that can provide solutions.
A lot of people are involved in the development of new pharmaceutical products, from engineers to operators, c-level leadership and more. As a result, digital transformations can seem daunting, as everyone must buy into the process for it to be successful.
But how do you convince them all? Especially when considering the complexity and time involved getting new treatments to market. Well, what if they could cut that timeline in half? What if treatments could get in the hands of patients faster, safer and reliably?
In this podcast you will learn:
(00:36) Where pharmaceutical companies get stuck during digital transformations
(10:55) What the scalable success of digital transformations looks like
(15:45) Firsthand expert best practices for digital transformations
About the voices:
Jan Wokittel, Director of Smart Manufacturing at Roche (linkedin.com/in/janwokittel/)
Jan is responsible for the digitization technologies used in greenfield pharmaceutical and medical device production facilities. For over seven years, he has helped Roche plan and implement large scale capital expenditure projects.
Andy Whytock, Head of Market Strategy and Thought Leadership of Life Sciences at Siemens (linkedin.com/in/andywhytock/)
Andy is responsible for driving digital transformation initiatives and thought leadership activities in the pharmaceutical and life sciences sector and specializes in helping life sciences manufacturers embrace digital transformation, adopt cutting-edge technologies and evolve into fully connected, data-driven and sustainable enterprises.
Conor Peick, Marketing Professional for the Thought Leadership team at Siemens Digital Industries Software (linkedin.com/in/conor-peick-119ab2143/)
Conor is responsible for creating forward-looking content for Siemens Digital Industries Software. He collaborates with industry experts and executives to produce impactful content exploring the challenges companies face and the technologies that can provide solutions.
